Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown remarkable success in treating skin cutaneous melanoma (SKCM); however, the response to treatment varies greatly between patients. Considering that the efficacy of ICI treatment is influenced by many factors, we selected the Fibrosheath inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Haoxuan, Lin, Anqi, Liang, Junyi, Zhang, Jian, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186463/
https://www.ncbi.nlm.nih.gov/pubmed/34113648
http://dx.doi.org/10.3389/fmolb.2021.629330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186463/
https://www.ncbi.nlm.nih.gov/pubmed/34113648
http://dx.doi.org/10.3389/fmolb.2021.629330

Ejemplares similares